Editorial: Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

被引：5
作者：
Grandi, Eleonora [1 ]
Morotti, Stefano [1 ]
Pueyo, Esther [2 ]
Rodriguez, Blanca [3 ]
机构：
[1] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
[2] Univ Zaragoza, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat Grp, IIS Aragon, Zaragoza, Spain
[3] Univ Oxford, Dept Comp Sci, Oxford, England
来源：
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
基金：
英国惠康基金;
关键词：
cardiotoxicity; QT interval prolongation; drug-induced arrhythmia; multi-scale modeling; cardiac electrophysiology; TORSADES-DE-POINTES; TRANSMURAL DISPERSION; MODELS; REPOLARIZATION; DRUGS; ELECTROPHYSIOLOGY; CONVERGENCE; SIMULATION; PREDICTION; DYNAMICS;
D O I：
10.3389/fphys.2018.00678
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] A case of lithium toxicity with significant QT interval prolongation
    Becker, T. K.
    Hariri, H.
    NOTFALL & RETTUNGSMEDIZIN, 2015, 18 (03): : 227 - 230
  • [42] Drug-induced QT interval prolongation: Do we know the risks?
    Villamanan, Elena
    Armada, Eduardo
    Ruano, Margarita
    MEDICINA CLINICA, 2015, 144 (06): : 269 - 274
  • [43] QT interval prolongation and bradycardia in lithium-induced nephrogenic diabetes insipidus
    La Rocca, Roberto
    Foschi, Antonella
    Preston, Ngambe Mandi
    Ceriani, Chiara
    Materia, Valeria
    Patane, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 162 (01) : E1 - E2
  • [44] Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients
    Tisdale, James E.
    Jaynes, Heather A.
    Kingery, Joanna R.
    Overholser, Brian R.
    Mourad, Noha A.
    Trujillo, Tate N.
    Kovacs, Richard J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (03): : 381 - 390
  • [45] Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist
    Uvelin, Arsen
    Pejakovic, Jasmina
    Mijatovic, Vesna
    JOURNAL OF ANESTHESIA, 2017, 31 (03) : 413 - 423
  • [46] Identification of Patients At-Risk of QT Interval Prolongation during Medication Reviews: A Missed Opportunity?
    Buss, Vera H.
    Lee, Kayla
    Naunton, Mark
    Peterson, Gregory M.
    Kosari, Sam
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [47] Papaverine-induced QT Interval Prolongation and Ventricular Fibrillation in a Patient with a History of Drug-induced QT Prolongation
    Goto, Masayuki
    Sato, Masahito
    Kitazawa, Hitoshi
    Takahashi, Minoru
    Fuse, Koichi
    Saito, Atsushi
    Okabe, Masaaki
    Aizawa, Yoshifusa
    INTERNAL MEDICINE, 2014, 53 (15) : 1629 - 1631
  • [48] Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram
    Berling, Ingrid
    Isbister, Geoffrey K.
    ANNALS OF EMERGENCY MEDICINE, 2015, 66 (02) : 154 - 164
  • [49] Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
    Niemeijer, Maartje N.
    van den Berg, Marten E.
    Eijgelsheim, Mark
    Rijnbeek, Peter R.
    Stricker, Bruno H.
    DRUG SAFETY, 2015, 38 (10) : 855 - 867
  • [50] Estimation of QT interval prolongation through model-averaging
    Bonate, Peter L.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (04) : 335 - 349
12345